Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04490057 · ClinicalTrials.gov registry record · Phase 4
A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV
A Phase 4 study of Tobacco Use Cessation, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 323
- Enrollment target
- 4
- Study locations
NCT04490057 is a Phase 4 study of Tobacco Use Cessation that has completed, run by Yale University. The registered enrollment target is 323 participants, below the 876-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (63% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT04490057, a Phase 4 study of Tobacco Use Cessation, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 323 participants
- Enrollment target
- 4
- Study locations
Study Summary
Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a group of PLWH.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
- DRUG Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler
- DRUG Varenicline or bupropion
Study Locations (4)
Connecticut
- Bridgeport Hospital Infectious Disease Clinic - Bridgeport
- Yale University School of Medicine - New Haven
New York
- SUNY Downstate STAR Clinic - Brooklyn
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2025-10-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04490057
The ClinicalTrials.gov registry entry for NCT04490057 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 876-participant average among 36 other Tobacco Use Cessation trials with a reported enrollment target (63% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tobacco Use Cessation appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management is the first listed.
NCT04490057 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, New York.
Frequently Asked Questions
What is clinical trial NCT04490057 about?
NCT04490057 is a clinical study titled "A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV". Many people living with HIV (PLWH) smoke. Smoking in these individuals is often undertreated. This study plans to assess the ability of various clinical pathways involving tobacco treatment medications and contingency management (paying smokers for not smoking) to improve smoking cessation in a grou...
What is the current status of trial NCT04490057?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 323 participants. The study started on 2020-07-27. Estimated completion is 2025-10-24.
What conditions does trial NCT04490057 study?
This clinical trial studies the following conditions: Tobacco Use Cessation.
What interventions are being tested in trial NCT04490057?
The interventions under investigation include: Contingency Management (BEHAVIORAL), Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler (DRUG), Varenicline or bupropion (DRUG).
Who is sponsoring clinical trial NCT04490057?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04490057 being conducted?
This trial has 4 study locations across Connecticut, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
ACTIVE NOT RECRUITING · Phase 4
-
Engagement With an Adaptive Mobile Health Smoking Cessation Intervention
COMPLETED · Phase 4
-
Cannabis-Tobacco Co-Use Treatment Study
RECRUITING · Phase 3
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.